Although, there are controversy in human medicine and some reports in human breast cancer and neuroblastoma did not show a clear correlation between β-AR mRNA levels and increased susceptibility to β-AR antagonist therapy [6, 12, 32]. This evidence concerns the gene ADRB2 and neuroblastoma.